Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

This publication has 25 references indexed in Scilit:

• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
  Endocrine Reviews, 1991
• Routine Inferior Petrosal Sinus Sampling in the Differential Diagnosis of Adrenocorticotropin (ACTH)-Dependent Cushing’s Syndrome: Early Recognition of the Occult Ectopic ACTH Syndrome
  Journal of Clinical Endocrinology & Metabolism, 1991
• Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors
  New England Journal of Medicine, 1990
• Parallelin Vivoandin VitroDetection of Functional Somatostatin Receptors in Human Endocrine Pancreatic Tumors: Consequences with Regard to Diagnosis, Localization, and Therapy
  Journal of Clinical Endocrinology & Metabolism, 1990
• Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion
  Journal of Endocrinological Investigation, 1990
• TREATMENT OF CUSHING'S SYNDROME WITH THE LONG‐ACTING SOMATOSTATIN ANALOGUE SMS 201‐995 (SANDOSTATIN)
  Clinical Endocrinology, 1990
• Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients.
  Radiology, 1989
• The effect of the long-acting somatostatin analogue SMS 201–995 on ACTH secretion in Nelson's syndrome and Cushing's disease
  Acta Endocrinologica, 1989
• LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
  The Lancet, 1989